Connect
MJA
MJA

Clinical practice guidelines: the need for greater transparency in formulating recommendations

Robert F W Moulds
Med J Aust 2011; 195 (6): 324-325. || doi: 10.5694/mja11.10875
Published online: 19 September 2011

To the Editor: Scott and Guyatt are absolutely correct that as much transparency as possible is required in the process by which any clinical guidelines are formulated.1 I also agree that this must include careful management of conflicts of interest, particularly in the selection of the members of the expert panels required to formulate guidelines and in the functioning of those panels.1

  • Robert F W Moulds

  • Therapeutic Guidelines Limited, Melbourne, VIC.

Correspondence: rmoulds@tg.org.au

Competing interests:

Robert Moulds is the medical advisor (part-time) to Therapeutic Guidelines Ltd, an independent, not-for-profit company that publishes clinical practice guidelines for use in Australian health care institutions and general practices.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.